News & Articles
Pharmaceutical News and Articles
Comprehensive and up-to-date drug news for both consumers and healthcare professionals.
Including medical news, pharmaceutical industry news, new drug approvals, applications and clinical trial results.
Daily MedNews
Here are some of the latest health and medical news developments, compiled by editors of HealthDay:
Basketball Legend Abdul-Jabbar Treated for Leukemia
Basketball great Kareem Abdul-Jabbar is being treated for chronic myeloid leukemia and has been...
(HealthDayNews) -- Here are the latest clinical trials, courtesy of ClinicalConnection.com:
Psoriasis
If you have moderate-to-severe plaque psoriasis, you may qualify for this study of an investigational medication. Participants will receive all...
TUESDAY, Nov. 10 -- Optical technology could help physicians detect small colorectal polyps during colonoscopies and save money, too, new research suggests.
In the report, published online Nov. 10 in The Lancet Oncology, the study authors explained...
TUESDAY, Nov. 10 -- Methods to gauge blood cholesterol to determine vascular disease risk can be simplified, researchers in England say.
Their method measures levels of either total or high-density lipoprotein (HDL, or "good" cholesterol) in the...
TUESDAY, Nov. 10 -- Even three years after finishing treatment for breast cancer, almost 50 percent of women report long-term pain, a new Danish study finds.
The research, published in the Nov. 11 issue of the Journal of the American Medical...
Pharma Industry News
Washington, D.C. (November 9, 2009) —
Pharmaceutical Research and Manufacturers of America (PhRMA) Senior
Vice President Ken Johnson issued the following statement regarding
the FDA’s Nov. 12-13 hearing (view
testimony | view
slide...
Audience: Anesthesiology and intensivist healthcare
professionals, hospital risk managers
ROCKVILLE, Md., Nov. 10, 2009-Hospira, Inc.and FDA
notified healthcare professionals of the recall of 85 lots of
Liposyn II 10%, Liposyn II 20%, Liposyn...
Electronic alerts persuade clinicians to switch from costly
drugs to generic brands
ROCHESTER, NY, November 09, 2009 - Simple computerized alerts
can help curb the impulse to prescribe unnecessarily expensive,
heavily marketed drugs, according to a...
ROCKVILLE, Md., Nov. 2, 2009--FDA notified healthcare
professionals of revisions to the prescribing information for
Byetta (exenatide) to include information on post-marketing reports
of altered kidney function, including acute renal failure...
5min and HealthCentral Announce New Online Health Video
Network
Reaches Largest Health Audience Online; 5min as Exclusive
Distribution Platform Enables Health Sites to Instantly Monetize
Relevant Video Content
ARLINGTON, VA AND NEW YORK (OCTOBER 28,...
New Drug Approvals
PRINCETON, N.J.--(BUSINESS WIRE)--Nov 5, 2009 - Bristol-Myers Squibb Company today announced that
the U.S. Food and Drug Administration (FDA) has approved a labeling
update for Reyataz to include long-term data from the
CASTLE Study. The CASTLE...
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Nov 5, 2009 - Gloucester
Pharmaceuticals announced today that the U.S. Food and Drug
Administration (FDA) approved Istodax (romidepsin)
for the treatment of cutaneous T-cell lymphoma (CTCL) in patients
who have...
ST. LOUIS & MISSISSAUGA, Ontario--(BUSINESS WIRE)--Nov 5,
2009 - Covidien, a leading global provider of healthcare
products, and Nuvo Research Inc., a Canadian drug
development company, today announced that the U.S. Food and Drug
Administration...
SAN DIEGO and INDIANAPOLIS, Oct. 30, 2009 /PRNewswire-FirstCall/
-- Amylin Pharmaceuticals, Inc. and Eli Lilly and Company today announced that the U.S. Food
and Drug Administration (FDA) has approved an expanded indication
for Byetta (exenatide)...
SILVER SPRING. Md., Oct. 26 /PRNewswire-USNewswire/ -- The U.S.
Food and Drug Administration today approved Arzerra (ofatumumab)
for patients with chronic lymphocytic leukemia (CLL), a slowly
progressing cancer of the blood and bone...
New Drug Applications
MELBOURNE, Australia, and MENLO PARK, California U.S.A. (10
November 2009) – ChemGenex Pharmaceuticals Limited announced today that the U.S. Food & Drug Administration (FDA)
has accepted the company's New Drug Application (NDA) for
Omapro...
Montreal, Canada – November 5, 2009 –
Theratechnologies today announced that the Endocrinologic
and Metabolic Drugs Advisory Committee of the U.S. Food and Drug
Administration ("FDA") will review
Theratechnologies’ NDA for tesamorelin in...
BRISBANE, Calif., Nov. 4 /PRNewswire-FirstCall/ -- InterMune,
Inc. today announced that it has
submitted an electronic New Drug Application (NDA) with the U.S.
Food and Drug Administration (FDA) seeking approval to market
pirfenidone for the...
CAMBRIDGE, Massachusetts, November 4/PRNewswire-FirstCall/ --
Shire plc, the global specialty
biopharmaceutical company, today announced that the United States
Food and Drug Administration (FDA) has granted Priority Review for
the New Drug...
MEMPHIS, Tenn.--(BUSINESS WIRE)--Nov 2, 2009 - GTx, Inc. today announced that it has received a Complete
Response Letter issued by the United States Food and Drug
Administration (FDA) regarding its New Drug Application (NDA) for
toremifene 80 mg...
Clinical Trials
WILMINGTON, Mass., Nov. 10 /PRNewswire/ -- The results of an
independent investigator study just published in the online version
of Dermatologic Surgery demonstrate that Levulan® Photodynamic
Therapy (PDT) may reduce the rate of recurrence of...
LAVAL, QC, Nov. 10 /PRNewswire-FirstCall/ -- Labopharm Inc.
(TSX: DDS; NASDAQ: DDSS) today announced an article has been
published in the international journal of neuropsychiatric
medicine, CNS Spectrums October, 2009 issue...
Schlieren (Zurich), Switzerland, November 10, 2009 – Cytos
Biotechnology Ltd (SIX:CYTN) today gave an update on the
development of its hypertension vaccine CYT006-AngQb. In a first
phase IIa study (study 01) the vaccine was safe, well tolerated...
ALISO VIEJO, Calif., November 10, 2009 - AVANIR
Pharmaceuticals, Inc. (NASDAQ: AVNR) today announced
efficacy, safety and tolerability results from the 12-week
open-label extension phase of the confirmatory Phase III STAR trial
evaluating the...
Basel, 10 November, 2009 -
Roche (SIX: RO, ROG; OTCQX: RHHBY) today reports results from a
320 patient phase II proof-of-concept study with it’s
investigational glycine transporter-1 inhibitor RG1678. The study
showed that the compound...
More News Resources
Daily MedNews
Pharma Industry News
New Drug Applications
New Drug Approvals
Clinical Trial Results
Generic Drug Approvals
Monthly Update Archive
